Clinical trial
AtriCure CryoICE Lesions for Persistent and Long-standing Persistent Atrial Fibrillation Treatment During Concomitant On-Pump Endo/Epicardial Cardiac Surgery
NCT03732794 is registered in ClinicalTrials.gov with AtriCure, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- AtriCure CryoICE Lesions for Persistent and Long-standing Persistent Atrial Fibrillation Treatment During Concomitant On-Pump Endo/Epicardial Cardiac Surgery
- Lead sponsor
- AtriCure, Inc.
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- January 30, 2019
- Completion date
- June 30, 2026
- Enrollment
- 150 (actual)
- Sites
- 15
Conditions
As the registry lists them; a condition with its own page is linked.
atrial fibrillation (af), longstanding persistent atrial fibrillation, persistent atrial fibrillation